lower
respiratori
tract
infect
lrti
young
children
common
reason
admiss
pediatr
intens
care
unit
picu
larg
major
lrti
children
believ
viral
origin
case
antibiot
treatment
would
howev
differenti
viral
bacteri
mix
infect
clinic
imposs
bacteria
cultur
consider
proport
therefor
children
ventil
lrti
treat
empir
unclear
whether
introduct
new
rapid
respiratori
viral
test
lrti
impact
antibiot
limit
number
studi
evalu
effect
rapid
diagnosi
antibiot
use
yield
contradictori
impact
viral
test
picu
set
investig
previous
rapid
viral
test
hospit
set
tradit
perform
direct
immunofluoresc
test
dif
current
molecular
amplif
test
polymeras
chain
reaction
pcr
becom
new
golden
standard
detect
respiratori
virus
increas
pcr
assay
shown
quick
reliabl
picu
popul
lead
larg
increas
diagnost
yield
respiratori
present
high
cost
pcr
assay
consid
disadvantag
aim
studi
evalu
whether
viral
diagnosi
obtain
sensit
pcr
compar
dif
would
impact
antibiot
prescript
children
admit
lrti
picu
answer
question
first
perform
multicent
survey
studi
among
picu
physician
subsequ
conduct
year
prospect
studi
picu
total
six
picu
three
larg
dutch
medic
center
univers
medic
center
utrecht
amsterdam
medic
center
erasmu
medic
center
rotterdam
three
larg
german
medic
center
univers
medic
center
freiburg
mainz
berlin
germani
particip
multicent
studi
senior
pediatr
intensivist
picu
list
picu
physician
involv
care
infant
lrti
picu
physician
individu
approach
investig
pediatr
intensivist
respons
questionnair
consist
five
case
descript
construct
clinic
data
five
infant
typic
sign
lrti
ventil
picu
infant
select
neg
indetermin
dif
test
posit
pcr
result
characterist
five
case
shown
supplementari
tabl
case
descript
follow
question
ask
would
startcontinu
antibiot
therapi
child
question
first
ask
pcr
result
conceal
question
repeat
disclos
pcr
result
anonym
respond
assur
questionnair
assur
clariti
coher
subsequ
modifi
respons
pilot
test
result
order
case
random
differ
questionnair
due
low
burden
survey
ethic
approvalinform
consent
need
accord
institut
review
board
hospit
ventil
patient
old
admit
lrti
picu
wilhelmina
children
hospit
dif
test
perform
part
routin
investig
enrol
octob
octob
wilhelmina
children
hospit
tertiari
care
medic
center
bed
picu
facil
serv
referr
center
central
part
netherland
exclus
criteria
asthma
exacerb
immun
compromis
state
indic
antibiot
lrti
repeat
picu
admiss
lrti
studi
period
baselin
clinic
data
obtain
medic
chart
use
standard
form
gender
age
symptom
onset
diseas
sever
antibiot
admiss
preterm
birth
underli
ill
durat
ventil
length
picu
stay
white
blood
count
protein
underli
ill
defin
chronic
pulmonari
diseas
congenit
heart
diseas
neurolog
diseas
gastrointestin
assess
ill
sever
oxygen
index
oi
calcul
hr
admiss
oi
fraction
inspir
oxygen
mean
airway
pressur
oxygen
pressur
nasopharyng
aspir
taken
train
nurs
staff
morn
first
work
day
admiss
work
day
specimen
examin
dif
pcr
previous
short
part
sampl
subject
dif
assay
detect
respiratori
syncyti
viru
rsv
influenza
virus
parainfluenza
virus
adenovirus
use
imagen
kit
dako
glostrup
denmark
accord
manufactur
recommend
protocol
indetermin
dif
result
consid
neg
analys
remain
materi
use
pcr
test
rsv
influenza
virus
parainfluenza
virus
adenovirus
rhinovirus
coronavirus
human
metapneumoviru
mycoplasma
pneumonia
second
year
newli
detect
human
bocaviru
ad
briefli
nucleic
acid
extract
use
magna
pure
lc
nucleic
acid
isol
system
roch
diagnost
basel
switzerland
amplif
carri
reaction
mixtur
fast
pcr
system
appli
biosystem
foster
citi
ca
posit
control
human
bocaviru
provid
alland
karolinska
institut
stockholm
sweden
intern
control
virus
use
monitor
effici
extract
amplif
patient
care
enrol
patient
left
discret
attend
picu
physician
result
dif
assay
time
approxim
hr
posit
result
report
end
first
work
day
attend
clinician
result
pcr
assay
time
hr
result
report
begin
second
work
day
investig
investig
approach
attend
physician
reveal
pcr
result
use
questionnair
follow
question
patient
suspect
clinic
diagnosi
answer
checkbox
viral
bronchiol
viral
pneumonia
bacteri
pneumonia
patient
treat
antibiot
subsequ
physician
provid
pcr
result
question
repeat
one
hour
later
final
picu
physician
ask
reason
di
continu
antibiot
sinc
prospect
studi
involv
chang
patient
manag
ethic
approv
andor
inform
consent
parentsguardian
infant
requir
accord
institut
review
board
hospit
statist
analysi
percentag
antibiot
use
disclosur
pcr
result
mcnemar
test
use
picu
physician
utrecht
amsterdam
rotterdam
freiburg
mainz
berlin
complet
questionnair
disclosur
pcr
result
percentag
picu
physician
would
treat
five
infant
antibiot
rang
five
case
fig
disclosur
pcr
result
percentag
physician
would
treat
infant
antibiot
decreas
mcnemar
test
p
case
absolut
reduct
largest
case
although
percentag
antibiot
use
test
differ
center
reduct
antibiot
use
follow
pcr
similar
differ
center
children
lrti
enrol
studi
twenti
children
clinic
suspect
viral
bronchiol
viral
pneumonia
bacteri
pneumonia
demograph
clinic
characterist
enrol
patient
provid
tabl
nineteen
patient
posit
dif
rsv
para
influenza
adenovirus
detect
fig
pcr
confirm
posit
dif
result
detect
addit
virus
tabl
remain
patient
dif
neg
dif
neg
patient
pcr
detect
total
virus
patient
lrti
viru
could
identifi
either
dif
pcr
therefor
infect
one
virus
detect
patient
group
dif
posit
patient
treat
antibiot
pcr
result
made
avail
antibiot
prescript
chang
reveal
concord
posit
pcr
result
fig
group
dif
neg
patient
patient
treat
antibiot
pcr
result
made
avail
pcr
posit
patient
none
patient
posit
pcr
result
prompt
picu
physician
discontinu
antibiot
patient
suspect
clinic
diagnosi
chang
attend
physician
bacteri
viral
pneumonia
nevertheless
antibiot
treatment
continu
ask
reason
continu
antibiot
physician
list
clinic
suspicion
bacteri
superinfect
set
protein
level
n
b
wait
final
result
bacteri
cultur
n
final
dif
neg
patient
treat
antibiot
neg
pcr
result
could
prompt
physician
start
antibiot
howev
patient
found
posit
pcr
respiratori
virus
pcr
confirm
clinic
suspicion
viral
infect
antibiot
start
summari
includ
patient
treat
antibiot
number
influenc
pcr
result
patient
believ
picu
physician
viral
lrti
viral
bronchiol
viral
pneumonia
antibiot
prescrib
present
studi
investig
impact
respiratori
viru
pcr
addit
dif
antibiot
prescript
ventil
children
lrti
picu
first
survey
studi
prospect
studi
although
physician
indic
pcr
would
effect
antibiot
use
survey
studi
effect
found
practic
prospect
studi
varieti
viral
test
current
use
diagnost
children
lrti
picu
convent
rapid
viral
test
antigen
detect
dif
replac
sensit
molecular
assay
pcr
led
increas
detect
substanti
increas
determin
pcr
theoret
could
influenc
daili
practic
picu
first
multicent
survey
studi
perform
sinc
survey
studi
indic
avail
pcr
result
would
reduc
antibiot
use
year
prospect
studi
undertaken
singl
center
test
impact
pcr
three
limit
studi
deserv
discuss
first
number
evalu
picu
children
prospect
studi
rel
small
howev
pcr
influenc
antibiot
prescript
one
singl
patient
therefor
believ
inclus
addit
patient
like
influenc
observ
impact
pcr
minor
second
fact
physician
awar
studi
may
influenc
decis
antibiot
prescript
howev
would
probabl
led
overestim
effect
pcr
result
antibiot
use
would
make
conclus
studi
stronger
third
turn
around
time
pcr
studi
hr
pcr
perform
work
day
result
avail
second
work
day
possibl
result
avail
earlier
could
effect
antibiot
prescript
practic
physician
probabl
reluct
stop
antibiot
treatment
start
howev
aim
evalu
impact
pcr
daili
practic
hospit
dif
pcr
perform
work
day
ie
turn
around
time
agreement
previou
studi
show
pcr
increas
diagnost
yield
consider
compar
dif
proport
children
increas
dif
pcr
number
virus
total
rsv
differ
type
increas
diagnost
yield
howev
accompani
decreas
antibiot
prescript
find
contrast
survey
studi
pcr
decreas
percentag
antibiot
descript
absolut
reduct
p
case
appar
treatment
paper
patient
treat
patient
daili
picu
practic
physician
seem
prefer
stay
safe
side
daili
practic
physician
seem
make
clinic
decis
ground
result
diagnost
investig
reason
stop
antibiot
treatment
pcr
posit
patient
clinic
suspicion
secondari
bacteri
super
infect
fact
result
bacteri
cultur
still
unknown
addit
lack
effect
pcr
antibiot
use
found
studi
one
may
wonder
effect
viral
test
dif
may
sinc
consider
proport
patient
receiv
antibiot
regardless
posit
dif
result
previou
studi
impact
rapid
viral
test
antibiot
use
children
publish
result
agreement
doan
et
poehl
et
find
reduct
antibiot
prescript
children
random
rapid
test
perform
emerg
depart
result
contrast
studi
bonner
et
noyola
sharma
et
woo
et
found
physician
prescrib
less
antibiot
patient
group
test
rapid
viral
test
studi
perform
emerg
depart
pediatr
ward
picu
assess
differ
age
group
expect
physician
picu
set
reluct
withhold
antibiot
treatment
sever
ill
popul
lrti
frequent
underli
diseas
reflect
popul
find
ventil
ltri
patient
children
start
antibiot
admiss
antibiot
prescript
chang
group
even
children
posit
pcr
neg
dif
addit
virtual
lrti
patient
picu
found
posit
pcr
one
virus
mean
picu
popul
viru
posit
help
clinician
anymor
differenti
patient
qualifi
antibiot
could
safe
treat
without
antibiot
therefor
propos
futur
pcr
studi
direct
set
patient
found
harbor
virus
popul
children
less
sever
respiratori
tract
infect
limit
antibiot
prescript
patient
viral
lrti
object
perform
respiratori
pcr
assay
pcr
valuabl
sensit
tool
explor
clinic
present
impact
respiratori
virus
well
epidemiolog
becom
even
import
diagnost
tool
antivir
treatment
becom
avail
howev
pcr
lrti
patient
picu
affect
daili
practic
test
could
left
diagnost
cost
could
save
conclus
daili
practic
pcr
addit
dif
test
impact
prescript
antibiot
ventil
lrti
patient
picu
contrast
respons
physician
paper
case
patient
theoret
survey
studi
show
discrep
theoret
consider
daili
practic
pediatr
intens
care
daili
practic
physician
seem
reluct
stop
antibiot
prescript
sever
ill
popul
lrti
patient
picu
